Expo showcased Israeli companies that are leading the way toward smart mobility
Oramed says it is months away from completing a Phase III clinical trial on what it hopes will become the world’s first oral insulin treatment for type 2 diabetics
Maayan Hoffman is a veteran American-Israeli journalist and strategic communications consultant.
She is the former news editor, head of strategy and senior health analyst for the Jerusalem Post, where she launched the outlet's Health & Wellness, Business & Innovation and Christian World portals.
Maayan has led content, marketing and strategy teams at top-tier corporations and NGOs, and has held senior journalism positions throughout the Jewish world, including serving as Editor-in-Chief of the Baltimore Jewish Times and Managing Editor of the Kansas City Jewish Chronicle.
Her work has appeared in the Washington Post, American Spectator, Fox, The Hill and Roll Call, among other places.